v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net income $ 38,052 $ 36,193
Reconciliations of net income to net cash used in operating activities:    
Depreciation and amortization 6,093 5,663
Non-cash operating lease expense 5,064 4,876
Net investment amortization (accretion) and losses (gains) recognized 335 (309)
Losses recognized on disposal of property 54  
Deferred income taxes 22  
Share-based compensation 7,791 6,648
Changes in certain operating assets and liabilities:    
Trade accounts receivable (66,083) (82,342)
Income taxes 2,336 5,191
Prepaid expenses and other (7,108) (325)
Accounts payable (945) (2,371)
Accrued payroll and related benefits 62,950 73,483
Payroll taxes payable (6,521) (38,457)
Other accrued liabilities 7,325 (245)
Premium payable (35,554) (15,689)
Workers' compensation claims liabilities (19,157) (30,735)
Operating lease liabilities (4,984) (5,066)
Other assets and liabilities, net 153 197
Net cash used in operating activities (10,177) (43,288)
Cash flows from investing activities:    
Purchase of property, equipment and software (13,281) (11,001)
Purchase of investments (7,669) (7,902)
Proceeds from sales and maturities of investments 15,715 10,871
Purchase of restricted investments (35,728) (27,542)
Proceeds from sales and maturities of restricted investments 68,346 64,596
Net cash provided by investing activities 27,383 29,022
Cash flows from financing activities:    
Proceeds from credit-line borrowings 4,508 415
Payments on credit-line borrowings (4,508) (415)
Repurchases of common stock (24,825) (22,125)
Common stock repurchased on vesting of restricted stock units and performance awards (5,967) (4,655)
Dividends paid (6,162) (6,011)
Proceeds from exercise of stock options and purchase of ESPP shares 3,201 931
Net cash used in financing activities (33,753) (31,860)
Net decrease in cash, cash equivalents and restricted cash (16,547) (46,126)
Cash, cash equivalents and restricted cash, beginning of period 82,588 74,841
Cash, cash equivalents and restricted cash, end of period $ 66,041 $ 28,715

Source